Patents by Inventor Daniel K. Kirchhofer

Daniel K. Kirchhofer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20240067752
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: September 26, 2023
    Publication date: February 29, 2024
    Inventors: Robert F. KELLEY, Daniel K. KIRCHHOFER, Joyce LAI, Chingwei V. LEE, Wei-Ching LIANG, Michael T. LIPARI, Kelly M. LOYET, Tao SAI, Menno VAN LOOKEREN CAMPAGNE, Yan WU, Germaine FUH
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230383008
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: October 21, 2022
    Publication date: November 30, 2023
    Inventors: Robert F. KELLEY, Daniel K. Kirchhofer, Joyce Lai, Chingwei V. Lee, Wei-Ching Liang, Michael T. Lipari, Kelly M. Loyet, Tao Sai, Menno Van Lookeren Campagne, Yan Wu, Germaine Fuh
  • Anti-HtrA1 antibodies and methods of use thereof
    Patent number: 11512143
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: November 29, 2022
    Assignee: Genentech, Inc.
    Inventors: Robert F. Kelley, Daniel K. Kirchhofer, Joyce Lai, Chingwei V. Lee, Wei-Ching Liang, Michael T. Lipari, Kelly M. Loyet, Tao Sai, Menno Van Lookeren Campagne, Yan Wu, Germaine Fuh
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20190375856
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: August 19, 2019
    Publication date: December 12, 2019
    Inventors: Robert F. KELLEY, Daniel K. KIRCHHOFER, Joyce LAI, Chingwei V. LEE, Wei-Ching LIANG, Michael T. LIPARI, Kelly M. LOYET, Tao SAI, Menno VAN LOOKEREN CAMPAGNE, Yan WU, Germaine FUH
  • Anti-HtrA1 antibodies and methods of use thereof
    Patent number: 10421821
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: September 24, 2019
    Assignee: Genentech, Inc.
    Inventors: Robert F. Kelley, Daniel K. Kirchhofer, Joyce Lai, Chingwei V. Lee, Wei-Ching Liang, Michael T. Lipari, Kelly M. Loyet, Tao Sai, Menno Van Lookeren Campagne, Yan Wu, Germaine Fuh
  • Anti-HtrA1 antibodies and methods of use thereof
    Patent number: 10421822
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: September 24, 2019
    Assignee: Genetech, Inc.
    Inventors: Robert F. Kelley, Daniel K. Kirchhofer, Joyce Lai, Chingwei V. Lee, Wei-Ching Liang, Michael T. Lipari, Kelly M. Loyet, Tao Sai, Menno Van Lookeren Campagne, Yan Wu, Germaine Fuh
  • NSP4 inhibitors and methods of use
    Patent number: 10246519
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: April 2, 2019
    Assignee: Genentech, Inc.
    Inventors: Shuo-Yen Jack Lin, Daniel K. Kirchhofer, Menno Van Lookeren Campagne
  • METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
    Publication number: 20190054138
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating binding of HGF ? chain to c-met.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 21, 2019
    Applicant: Genentech, Inc.
    Inventors: Daniel K. Kirchhofer, Robert A. Lazarus, Xiaoyi Yao
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20190048097
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 14, 2019
    Inventors: Robert F. Kelley, Daniel K. Kirchhofer, Joyce Lai, Chingwei V. Lee, Wei-Ching Liang, Michael T. Lipari, Kelly M. Loyet, Tao Sai, Menno Van Lookeren Campagne, Yan Wu, Germaine Fuh
  • NSP4 INHIBITORS AND METHODS OF USE
    Publication number: 20180371107
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Application
    Filed: April 20, 2018
    Publication date: December 27, 2018
    Applicant: Genentech, Inc.
    Inventors: Shuo-Yen Jack LIN, Daniel K. KIRCHHOFER, Menno VAN LOOKEREN CAMPAGNE
  • NSP4 inhibitors and methods of use
    Patent number: 9975963
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: May 22, 2018
    Assignee: Genentech, Inc.
    Inventors: Shuo-Yen Jack Lin, Daniel K. Kirchhofer, Menno Van Lookeren Campagne
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20170145113
    Abstract: The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
    Type: Application
    Filed: October 27, 2016
    Publication date: May 25, 2017
    Inventors: Robert F. KELLEY, Daniel K. KIRCHHOFER, Joyce LAI, Chingwei V. LEE, Wei-Ching LIANG, Michael T. LIPARI, Kelly M. LOYET, Tao SAI, Menno VAN LOOKEREN CAMPAGNE, Yan WU, Germaine FUH
  • METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
    Publication number: 20170106042
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating binding of HGF ? chain to c-met.
    Type: Application
    Filed: May 23, 2016
    Publication date: April 20, 2017
    Applicant: Genentech, Inc.
    Inventors: Daniel K. Kirchhofer, Robert A. Lazarus, Xiaoyi Yao
  • ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE
    Publication number: 20160355606
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 8, 2016
    Inventors: Yan Wu, Cecilia Pui Chi Chiu, Daniel K. Kirchhofer, Andrew Peterson, Ganesh A. Kolumam, Monica Kong Beltran, Paul Moran, Wei Li, Xanthe Lam, Lin Luis, Ada Hui, Whittemore Tingley, John Douglas Davis, Nageshwar R. Budha
  • NSP4 INHIBITORS AND METHODS OF USE
    Publication number: 20160215065
    Abstract: The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
    Type: Application
    Filed: April 8, 2016
    Publication date: July 28, 2016
    Applicant: Genentech, Inc.
    Inventors: Shuo-Yen Jack LIN, Daniel K. KIRCHHOFER, Menno VAN LOOKEREN CAMPAGNE
  • Anti-PCSK9 antibodies, formulations, dosing, and methods of use
    Patent number: 9266961
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: February 23, 2016
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Cecilia Pui Chi Chiu, Daniel K. Kirchhofer, Andrew Peterson, Ganesh A. Kolumam, Monica Kong Beltran, Paul Moran, Wei Li, Xanthe M. Lam, Lin Luis, Ada Hui
  • METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
    Publication number: 20150126448
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating binding of HGF ? chain to c-met.
    Type: Application
    Filed: June 26, 2014
    Publication date: May 7, 2015
    Applicant: GENENTECH, INC.
    Inventors: Daniel K. Kirchhofer, Robert A. Lazarus, Xiaoyi Yao
  • Antibodies to hepatocyte growth factor activator
    Patent number: 8969528
    Abstract: The invention provides methods and compositions for modulating hepatocyte growth factor activator function.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: March 3, 2015
    Assignee: Genentech, Inc
    Inventors: Daniel K. Kirchhofer, Yan Wu
  • PCSK9-BINDING POLYPEPTIDES AND METHODS OF USE
    Publication number: 20140212431
    Abstract: The invention provides PCSK9-binding polypeptides and methods of using the same.
    Type: Application
    Filed: December 19, 2013
    Publication date: July 31, 2014
    Applicant: GENENTECH, INC.
    Inventors: Daniel K. Kirchhofer, Yingnan Zhang, Andrew Scott Peterson, Wei Li, Monica Kong-Beltran, Lijuan Zhou
  • ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE
    Publication number: 20130344085
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Application
    Filed: June 14, 2013
    Publication date: December 26, 2013
    Inventors: Yan WU, Cecilia Pui Chi CHIU, Daniel K. KIRCHHOFER, Andrew PETERSON, Ganesh A. KOLUMAM, Monica Kong BELTRAN, Paul MORAN, Wei LI, Xanthe LAM, Lin LUIS, Ada HUI, Whittemore TINGLEY, John Douglas DAVIS, Nageshwar R. BUDHA